Aliri
Aliri is a premier bioanalytical CRO that leverages advanced spatial imaging and artificial intelligence to enhance drug development processes. With over 30 years of experience, Aliri provides comprehensive bioanalysis services, including method development, sample analysis, and spatial biology solutions, ensuring regulatory compliance and timely data for clients. Their innovative approach and commitment to operational excellence position them as a leader in the bioanalytical field, helping clients advance their molecules from discovery to clinical development efficiently.
Aliri
Aliri is a premier bioanalytical CRO that leverages advanced spatial imaging and artificial intelligence to enhance drug development processes. With over 30 years of experience, Aliri provides comprehensive bioanalysis services, including method development, sample analysis, and spatial biology solutions, ensuring regulatory compliance and timely data for clients. Their innovative approach and commitment to operational excellence position them as a leader in the bioanalytical field, helping clients advance their molecules from discovery to clinical development efficiently.
TL;DR
What they do: Bioanalytical CRO specializing in spatial biology, mass spectrometry, and AI-driven bioanalysis
Formation: Unified brand formed from Pyxant Labs, ImaBiotech, and Tandem Labs (announced May 23, 2023)
Backing: Backed by healthcare private equity firm ArchiMed SAS
Headcount: Approximately 124 employees
Company Overview
Problem Domain
Bioanalysis and spatial biology for biotech and pharma drug development
Industry
Biotechnology / Contract Research Organization (CRO)
Funding Track Record
Listed as one funding event on third-party profile classified as Non-equity Assistance
Investor Signal
“Backed by ArchiMed SAS (private equity, healthcare-focused)”